Abiopharma

Change in the company’s holdings in Citycon, holds approximately 86.82%

Periodic and annual report for the year 2025 – iXBRL report

FORM N-2-REGISTRATION STATEMENT-POST-EFFECTIVE AMENDMENT NO. 20

Other Report or Announcement

Rimini Street公布2026會計年度第二季財務與經營業績

Rimini Street anuncia los resultados financieros y operativos del segundo trimestre del ejercicio fiscal 2026

General Announcement: Corrigendum to the FY2026 Results Announcement and the Annual Report for FY2026

WIX Investors Have Opportunity to Lead Wix.com Ltd. Securities Fraud Lawsuit

ADMA Deadline: ADMA Investors with Losses in Excess of $100K Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

WGS Deadline: WGS Investors with Losses in Excess of $100K Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit